RecruitingNot ApplicableNCT03684109
Non-invasive Glioma Characterization Through Molecular Imaging
Pilot Study for Non-invasive Glioma Characterization Through Molecular Imaging
Sponsor
University of Miami
Enrollment
30 participants
Start Date
Jan 25, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Adults (≥18 year old)
- Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion.
Exclusion Criteria4
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Patients unable to have MRI done
Interventions
DEVICE3T MRI Scanner
3T MRI Scanner providing Mega-laser sequence for single-voxel Magnetic Resonance Spectroscopy (MRS) data for 2 hydroxyglutarate (2HG) quantitation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03684109
Related Trials
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
NCT062294831 location
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
NCT073265661 location
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
NCT061615191 location
Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment
NCT063527101 location
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NCT040334972 locations